[e2e] was double blind, now reproduceable results

David P. Reed dpreed at reed.com
Thu May 20 06:25:04 PDT 2004

At 01:44 AM 5/20/2004, Jon Crowcroft wrote:
>look, if the medical world, with all the finanical and ethical pressures 
>on them
>can manage with this problemm (esp. viz genomics, protemics, patent 
>fights, patient privacy, and
>pharma indutry), then we are pretty sad if we can't figure it out

The medical world has not figured this out.   In discussions with 
colleagues, there are lots of points where data is withheld and techniques 
are withheld from researchers who would like to reproduce results.   They 
are struggling with tough issues as well, plus new issues (such as 
professors and patent law extremists who are working to build case law that 
research use of patented ideas can be blocked - the whole idea of a 
"research exception" is being systematically attacked by the patent bar in 
areas of medicine).

At least in our arena, we have been building a movement toward open source, 
open ideas, etc. (one that I am proud to be a member of).   There is little 
of that in biomedical science today. 

More information about the end2end-interest mailing list